Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation

Francesco Iuliano, MD, Eleonora Iuliano, MD, Marco Rossi, MD

Blood (2018) 132 (Supplement 1): 2449.

https://doi.org/10.1182/blood-2018-99-118518

Published: 2018

Journal Articles

Assisted Administration of Subcutaneous Rituximab to the Patient's Home. Significant Reduction of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together with a Total Adherence to the Treatment Schedule and Same Safety

Francesco Iuliano, MD, Eleonora Iuliano, MD, Marco Rossi, MD

Blood (2018) 132 (Supplement 1): 5869.

https://doi.org/10.1182/blood-2018-99-118756

Published: 2018

Journal Articles

Observational Study of CML Italian Patients Who Discontinued TKIs

Carmen Fava, MD PhD, Giovanna Rege-Carmbrin, Irene Dogliotti, Marco Cerrano, Paola Berchialla, Gianantonio Rosti, MD, Fausto Castagnetti, MD PhD, Gabriele Gugliotta, MD PhD, Bruno Martino, Carlo Gambacorti-Passerini, MD, Elisabetta Abruzzese, MD PhD, Ester Maria Orlandi, MD, Chiara Elena, Patrizia Pregno, Antonella Gozzini, MD, Paolo Avanzini, MD, Micaela Bergamaschi, MD, Monica Crugnola, MD, Monica Bocchia, Sara Galimberti, PhD MD, Davide Rapezzi, MD, Alessandra Iurlo, MD PhD, Daniele Cattaneo, MD, Roberto Latagliata, Massimo Breccia, MD, PhD, Michele Cedrone, MD, Marco Santoro, MD, Mario Annunziata, MD, Luciano Levato, MD, Fabio Stagno, MD PhD, Francesco Cavazzini, MD, Nicola Sgherza, Valentina Giai, Luigiana Luciano, Sabina Russo, Pellegrino Musto, MD, Giovanni Caocci, MD, Federica SORA, MD, Francesco Iuliano, Francesca Lunghi, MD, Giorgina Specchia, MD, Fabrizio Pane, MD, Michele Baccarani, MD, Dario Ferrero, Giuseppe Saglio, MD PhD

Blood (2017) 130 (Supplement 1): 1616.

https://doi.org/10.1182/blood.V130.Suppl_1.1616.1616

Published: 2017

Journal Articles

Rituximab Subcutaneous Formulation (SC-R) Is Safe, Effective and Cost-Saving in Patients Suffering from Autoimmune Hemolytic Anemia (AIHA)

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Maria Luci, MD, Maria Aquila Santoro, MD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2016) 128 (22): 1269.

https://doi.org/10.1182/blood.V128.22.1269.1269

Published: 2016

Journal Articles

Low Doses of Eltrombopag Are Safe and Effective in the Prophylaxis of the Chemotherapy-Induced Thrombocytopenia (CIT)

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Maria Aquila Santoro, MD, Angelo Pomillo, MD, Maria Luci, MD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2016) 128 (22): 4926.

https://doi.org/10.1182/blood.V128.22.4926.4926

Published: 2016

Journal Articles

Effectiveness and Safety of Low Dose Eltrombopag Twice Weekly in ITP Patients That Achieved CR after 50mg Daily Standard Dose

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Maria Luci, MD, Elisabetta Abruzzese

Blood (2014) 124 (21): 2788.

https://doi.org/10.1182/blood.V124.21.2788.2788

Published: 2014

Journal Articles

Subcutaneous Immunoglobulin (SCIG) in Responders to Intravenous Therapy with Chronic Immune Thrombocytopenia (ITP)

Francesco Iuliano, MD, Eleonora Iuliano, MD, Maria Luci, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Elisabetta Abruzzese

Blood (2014) 124 (21): 5012.

https://doi.org/10.1182/blood.V124.21.5012.5012

Published: 2014

Journal Articles

Assisted Administration Of Subcutaneous 5-Azacytidine to The Patient's Home. Significant Reduction Of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together With a Total Adhesion To The Treatment Schedule and Same Safety

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Maria Luci, MD, Gianluca Cervo

Blood (2013) 122 (21): 5587.

https://doi.org/10.1182/blood.V122.21.5587.5587

Published: 2013

Journal Articles

Platelet Kinetic Study (PKS) May Early Identify a Subset of Patients with Immune Thrombocytopenia (ITP) Probably Cured by Romiplostim. Two Years Follow-up

Francesco Iuliano, MD, Alessia Perricelli, MD, Eleonora Iuliano, MD, Stefania Infusino, PhD, Angelo Pomillo, MD, Maria Luci, MD, Filippo Barbano, MD

Blood (2012) 120 (21): 1099.

https://doi.org/10.1182/blood.V120.21.1099.1099

Published: 2012

Journal Articles

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Esther Natalie Oliva, Francesco Albano, Nicola Di Renzo, Vincenzo Pavone, Stefano Molica, Fortunato Morabito, Attilio Guarini, Giuseppe Tarantini, Silvana Capalbo, MD, Emilio Iannitto, Giovanni Quarta, MD, Nicola Cascavilla, Pierfrancesco Tassone, MD, Francesco Iuliano, Roberto Porciello, Paola Casieri, Carmelo Laganà, Francesco Nobile, Giorgina Specchia

Blood (2012) 120 (21): 50623.

https://doi.org/10.1182/blood.V120.21.50623.50623

Published: 2012

Journal Articles

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Blood (2012) 120 (21): 5200.

https://doi.org/10.1182/blood.V120.21.5200.5200

Published: 2012

Journal Articles

Rituximab, Endoxan, Ganciclovir, Dexamethasone, Tocilizumab Sequential Treatment In Kaposi's Sarcoma-Associated Herpesvirus (KSHV) -Related Multicentric Castleman Disease. A Case Report with 8 Months Follow-up

Francesco Iuliano, Tecla Mingrone, Stefania Infusino, Alessia Perricelli, Angelo Pomillo, Maria Luci, Massimo Di Maio

Blood (2010) 116 (21): 4872.

https://doi.org/10.1182/blood.V116.21.4872.4872

Published: 2010

Journal Articles

Romiplostim Treatment Mimicking Cyclic Thrombocytopenia In 3 Patients with Chronic Idiopatic Thrombocytopenic Purpura

Francesco Iuliano, Tecla Mingrone, Stefania Infusino, Alessia Perricelli, Angelo Pomillo, Maria Luci, Massimo Di Maio

Blood (2010) 116 (21): 4665.

https://doi.org/10.1182/blood.V116.21.4665.4665

Published: 2010

Journal Articles

Resveratrol Plus Simvastatin Are Effective in Decreasing IgM Secretion in Asymptomatic Waldenstrom Macroglobulinemia. One Year Follow-up.

Francesco Iuliano, Stefania Infusino, Alessia Perricelli, Massimo Di Maio, Angelo Pomillo, Maria Luci, Francesco Mingrone

Blood (2009) 114 (22): 4401.

https://doi.org/10.1182/blood.V114.22.4401.4401

Published: 2009

Journal Articles

BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial.

Blood (2009) 114 (22): 648.

https://doi.org/10.1182/blood.V114.22.648.648

Published: 2009

Journal Articles

Methanolic Extract of Cynara Cardunculus L. Inhibits Cell Proliferation and Bcr/Abl Expression in K562 Cell Line

Antonio Russo, Filomena Conforti, Maria Cristina Caroleo, Roberta Ionà, Giancarlo Statti, Francesco Iuliano

Blood (2008) 112 (11): 4247.

https://doi.org/10.1182/blood.V112.11.4247.4247

Published: 2008

Journal Articles

09:00–09:05Escalated Dasatinib Dose up to 60 Mg O.D. in Elderly Patients with Chronic Myeloid Leukemia in Late Chronic Phase Resistant to or Intolerant of Imatinib-12 Months Follow-up

Francesco Iuliano, Antonio Russo, Maria Cristina Caroleo, Filomena Conforti, Anna Serra

Blood (2008) 112 (11): 4283.

https://doi.org/10.1182/blood.V112.11.4283.4283

Published: 2008

Journal Articles

REP Regimen (Rituximab, Erythropoietin and Prednisone) in the Treatment of Refractory Autoimmune Hemolytic Anemia (R-AIHA).

Francesco Iuliano, Massimo Di Maio, Stefania Infusino, Alessia Perricelli, Angelo Pomillo, Antonio Russo, Amalia Giuliano, Vincenzo Pata

Blood (2008) 112 (11): 3842.

https://doi.org/10.1182/blood.V112.11.3842.3842

Published: 2008

Journal Articles

Efficacy and Tolerability of Pregabalin in Decreasing Pain Associated with High Dose of Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase CML.

Francesco Iuliano, MD, Massimo DI Maio, MD, Stefania Infusino, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Daniela Cilloni, MD, Giuseppe Saglio, MD

Blood (2007) 110 (11): 4570.

https://doi.org/10.1182/blood.V110.11.4570.4570

Published: 2007

Journal Articles

Phase II Study of Liposome Encapsulated Doxorubicin Citrate Complex, NPLD (Myocet™) in Myelofibrosis with Myeloid Metaplasia (MMM).

Francesco Iuliano, MD, Daniela Cilloni, MD, Molica Stefano, MD, Sterpone Paola, Di Maio Massimo, MD, Gottardi Enrico, Messa Emanuela, Serra Anna, Peta Antonio, MD

Blood (2006) 108 (11): 3621.

https://doi.org/10.1182/blood.V108.11.3621.3621

Published: 2006

NARROW

Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation

Assisted Administration of Subcutaneous Rituximab to the Patient's Home. Significant Reduction of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together with a Total Adherence to the Treatment Schedule and Same Safety

Observational Study of CML Italian Patients Who Discontinued TKIs

Rituximab Subcutaneous Formulation (SC-R) Is Safe, Effective and Cost-Saving in Patients Suffering from Autoimmune Hemolytic Anemia (AIHA)

Low Doses of Eltrombopag Are Safe and Effective in the Prophylaxis of the Chemotherapy-Induced Thrombocytopenia (CIT)

Effectiveness and Safety of Low Dose Eltrombopag Twice Weekly in ITP Patients That Achieved CR after 50mg Daily Standard Dose

Subcutaneous Immunoglobulin (SCIG) in Responders to Intravenous Therapy with Chronic Immune Thrombocytopenia (ITP)

Assisted Administration Of Subcutaneous 5-Azacytidine to The Patient's Home. Significant Reduction Of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together With a Total Adhesion To The Treatment Schedule and Same Safety

Platelet Kinetic Study (PKS) May Early Identify a Subset of Patients with Immune Thrombocytopenia (ITP) Probably Cured by Romiplostim. Two Years Follow-up

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy

Rituximab, Endoxan, Ganciclovir, Dexamethasone, Tocilizumab Sequential Treatment In Kaposi's Sarcoma-Associated Herpesvirus (KSHV) -Related Multicentric Castleman Disease. A Case Report with 8 Months Follow-up

Romiplostim Treatment Mimicking Cyclic Thrombocytopenia In 3 Patients with Chronic Idiopatic Thrombocytopenic Purpura

Resveratrol Plus Simvastatin Are Effective in Decreasing IgM Secretion in Asymptomatic Waldenstrom Macroglobulinemia. One Year Follow-up.

BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial.

Methanolic Extract of Cynara Cardunculus L. Inhibits Cell Proliferation and Bcr/Abl Expression in K562 Cell Line

09:00–09:05Escalated Dasatinib Dose up to 60 Mg O.D. in Elderly Patients with Chronic Myeloid Leukemia in Late Chronic Phase Resistant to or Intolerant of Imatinib-12 Months Follow-up

REP Regimen (Rituximab, Erythropoietin and Prednisone) in the Treatment of Refractory Autoimmune Hemolytic Anemia (R-AIHA).

Efficacy and Tolerability of Pregabalin in Decreasing Pain Associated with High Dose of Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase CML.

Phase II Study of Liposome Encapsulated Doxorubicin Citrate Complex, NPLD (Myocet™) in Myelofibrosis with Myeloid Metaplasia (MMM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only